Fig. 2

Kaplan-Meier survival analysis by MACC1 and KAI1 status. The y-axis represents the percentage of patient; the x-axis, their survival in months. The green line represents patients with positive expression of MACC1 (a) or KAI1 (b) with a trend of worse or better survival time than the blue line representing the negative MACC1 group or KAI1 group (P < 0.001). Mean survival time was 32.7 months for the positive expression of the MACC1 group and 56.1 months for the negative MACC1 group. Mean survival time was 52.6 months for the positive expression of the KAI1 group and 34.5 months for the negative KAI1 group (n = 325)